2004
DOI: 10.1136/bmj.38040.607141.ee
|View full text |Cite
|
Sign up to set email alerts
|

Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain

Abstract: Objective To determine the efficacy and safety of topical rubefacients containing salicylates in acute and chronic pain. Data sources Electronic databases and manufacturers of salicylates. Study selection Randomised double blind trials comparing topical rubefacients with placebo or another active treatment, in adults with acute or chronic pain, and reporting dichotomous information, around a 50% reduction in pain, and analyses at one week for acute conditions and two weeks for chronic conditions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
49
1
3

Year Published

2006
2006
2017
2017

Publication Types

Select...
4
4
1

Relationship

3
6

Authors

Journals

citations
Cited by 99 publications
(54 citation statements)
references
References 24 publications
1
49
1
3
Order By: Relevance
“…In acute conditions the NNT was 2.1; in chronic conditions the NNT was 5.3. It was concluded that topical salicylates may have efficacy in acute pain at seven days, but poor to moderate efficacy for chronic pain at 14 days (250). Table 18 presents the topical NSAIDs and some of the rubefacients available in Canada.…”
Section: Topical Analgesicsmentioning
confidence: 99%
“…In acute conditions the NNT was 2.1; in chronic conditions the NNT was 5.3. It was concluded that topical salicylates may have efficacy in acute pain at seven days, but poor to moderate efficacy for chronic pain at 14 days (250). Table 18 presents the topical NSAIDs and some of the rubefacients available in Canada.…”
Section: Topical Analgesicsmentioning
confidence: 99%
“…Additionally their efficacy may be over-estimated as adequate blinding is not possible with any trial involving a rubefacient, the mechanism of action is through local irritation and any sham preparation, which attempts to mimic this, would be a rubefacient itself. However, placebo gels in trials were rubbed on to the skin in the same way as the active treatment overcoming any additional therapeutic effect of rubbing (52).…”
Section: Topical Counter-irritantsmentioning
confidence: 99%
“…Based on limited data, rubefacients appear well tolerated and local adverse effects are uncommon in the short term (2% of patients) (51,52). Currently they are usually used as adjuvants to other therapies, such as oral analgesics, support bandages, rest, ice, and compression, and may be useful for patients who cannot tolerate oral analgesics (52).…”
Section: Topical Counter-irritantsmentioning
confidence: 99%
“…Muscle relaxants are typically recommended as adjuvant therapy and seem to have a restricted role in the treatment of chronic, non-cancer pain [22,23]. Topical agents have also been shown to effectively reduce chronic pain in comparison to placebo [24].…”
Section: Pharmacological Treatmentsmentioning
confidence: 99%